197 related articles for article (PubMed ID: 30292461)
1. Enhancement Patterns of Intrahepatic Cholangiocarcinoma on Contrast-Enhanced Ultrasound: Correlation with Clinicopathologic Findings and Prognosis.
Yuan M; Li R; Zhang Y; Yang L; Zhang X; Tang C; Guo D
Ultrasound Med Biol; 2019 Jan; 45(1):26-34. PubMed ID: 30292461
[TBL] [Abstract][Full Text] [Related]
2. Factors Affecting the Enhancement Patterns of Intrahepatic Cholangiocarcinoma (ICC) on Contrast-Enhanced Ultrasound (CEUS) and their Pathological Correlations in Patients with a Single Lesion.
Yuan MX; Li R; Zhang XH; Tang CL; Guo YL; Guo DY; Luo MK
Ultraschall Med; 2016 Dec; 37(6):609-618. PubMed ID: 25919414
[No Abstract] [Full Text] [Related]
3. Dynamic enhancement pattern of intrahepatic cholangiocarcinoma on contrast-enhanced ultrasound: the correlation with cirrhosis and tumor size.
Lu Q; Xue LY; Wang WP; Huang BJ; Li CX
Abdom Imaging; 2015 Aug; 40(6):1558-66. PubMed ID: 25725793
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound.
Chen LD; Ruan SM; Liang JY; Yang Z; Shen SL; Huang Y; Li W; Wang Z; Xie XY; Lu MD; Kuang M; Wang W
World J Gastroenterol; 2018 Sep; 24(33):3786-3798. PubMed ID: 30197484
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced ultrasound (CEUS) for differentiating between hepatocellular and cholangiocellular carcinoma.
Bohle W; Clemens PU; Heubach T; Zoller WG
Ultraschall Med; 2012 Dec; 33(7):E191-E195. PubMed ID: 22194045
[TBL] [Abstract][Full Text] [Related]
6. Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern--correlation with clinicopathologic findings.
Kim SA; Lee JM; Lee KB; Kim SH; Yoon SH; Han JK; Choi BI
Radiology; 2011 Jul; 260(1):148-57. PubMed ID: 21474703
[TBL] [Abstract][Full Text] [Related]
7. Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma.
Asayama Y; Yoshimitsu K; Irie H; Tajima T; Nishie A; Hirakawa M; Nakayama T; Kakihara D; Taketomi A; Aishima S; Honda H
Radiology; 2006 Jan; 238(1):150-5. PubMed ID: 16304089
[TBL] [Abstract][Full Text] [Related]
8. Gadoxetic acid disodium-enhanced MR imaging of cholangiolocellular carcinoma of the liver: imaging characteristics and histopathological correlations.
Haradome H; Unno T; Morisaka H; Toda Y; Kwee TC; Kondo H; Sano K; Ichikawa T; Kondo F; Sugitani M; Takayama T
Eur Radiol; 2017 Nov; 27(11):4461-4471. PubMed ID: 28439650
[TBL] [Abstract][Full Text] [Related]
9. Role of Central Hypo-enhancement in the Hepatic Arterial Phase of Dynamic Computed Tomography in Patients with Mass-Forming Intrahepatic Cholangiocarcinoma.
Teraoku H; Morine Y; Uyama N; Ikemoto T; Iwahashi S; Saito Y; Takasu C; Imura S; Harada M; Shimada M
World J Surg; 2020 Jul; 44(7):2350-2358. PubMed ID: 32152739
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced ultrasound of intrahepatic cholangiocarcinoma: correlation with pathological examination.
Xu HX; Chen LD; Liu LN; Zhang YF; Guo LH; Liu C
Br J Radiol; 2012 Aug; 85(1016):1029-37. PubMed ID: 22374276
[TBL] [Abstract][Full Text] [Related]
11. Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic Liver.
Dong Y; Chen S; Möller K; Qiu YJ; Lu XY; Zhang Q; Dietrich CF; Wang WP
Ultrasound Med Biol; 2023 Aug; 49(8):1780-1788. PubMed ID: 37156676
[TBL] [Abstract][Full Text] [Related]
12. Imaging features of combined hepatocellular-cholangiocarcinoma on contrast-enhanced ultrasound: correlation with clinicopathological findings.
Ye J; Xie X; Lin Y; Liu B; Wang W; Huang X; Huang G
Clin Radiol; 2018 Mar; 73(3):237-243. PubMed ID: 29122222
[TBL] [Abstract][Full Text] [Related]
13. Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT.
Chen LD; Xu HX; Xie XY; Lu MD; Xu ZF; Liu GJ; Liang JY; Lin MX
Br J Radiol; 2008 Nov; 81(971):881-9. PubMed ID: 18941048
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic Mass-forming Cholangiocarcinoma: Arterial Enhancement Patterns at MRI and Prognosis.
Min JH; Kim YK; Choi SY; Kang TW; Lee SJ; Kim JM; Ahn S; Cho H
Radiology; 2019 Mar; 290(3):691-699. PubMed ID: 30620253
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma.
Wildner D; Pfeifer L; Goertz RS; Bernatik T; Sturm J; Neurath MF; Strobel D
Ultraschall Med; 2014 Dec; 35(6):522-7. PubMed ID: 25202903
[TBL] [Abstract][Full Text] [Related]
16. Dynamic enhancing vascular pattern of intrahepatic peripheral cholangiocarcinoma on contrast-enhanced ultrasound: the influence of chronic hepatitis and cirrhosis.
Li R; Zhang X; Ma KS; Li XW; Xia F; Zhong H; Tang CL; Guo Y; Yan XC
Abdom Imaging; 2013 Feb; 38(1):112-9. PubMed ID: 22323003
[TBL] [Abstract][Full Text] [Related]
17. Value of contrast-enhanced sonography in the diagnosis of peripheral intrahepatic cholangiocarcinoma.
Li C; Wang W; Ding H; Huang B; Cao J; Mao F; Ji Z
J Clin Ultrasound; 2011 Oct; 39(8):447-53. PubMed ID: 21626512
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
Zhao YJ; Chen WX; Wu DS; Zhang WY; Zheng LR
Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
[TBL] [Abstract][Full Text] [Related]
19. Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis.
Li R; Yuan MX; Ma KS; Li XW; Tang CL; Zhang XH; Guo DY; Yan XC
PLoS One; 2014; 9(5):e98612. PubMed ID: 24874413
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced ultrasound features predict the prognosis of percutaneous microwave ablation of intrahepatic cholangiocarcinoma.
Wang X; Liang P; Yu J; Yao JD; Fan FY; Yu X; Cheng ZG; Han ZY; Liu FY; Dou JP
Br J Radiol; 2022 May; 95(1133):20211379. PubMed ID: 35138914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
